The serum profile of adipokines in overweight patients with metabolic syndrome

Endokrynologia Polska

Volumn 61, Issue 1, 2010, Pages 36-41

  Gnacińska, Maria ^a   Małgorzewicz, Sylwia ^a   Łysiak Szydłowska, Wiesława ^a   Sworczak, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Adipokines; Metabolic syndrome; Obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LEPTIN; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOKINES; ADIPONECTIN; ADULT; CHOLESTEROL, HDL; FEMALE; HUMANS; INTERLEUKIN-6; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OVERWEIGHT; TRIGLYCERIDES; YOUNG ADULT;

EID: 77950547232     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Pudel V, Ellrott T. Adipositas - ein gesellschaftspolirjsches Problem? Chirurg 2005; 76: 639-646.
2. Reincke M. Adipositas und Innere Medizin. Internist 2006; 47:109. (Pubitemid 43260914)
3. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a World Health Organization Consultation. Geneva, Switzerland: World Health Organization, 2000. WHO Obesity Technical Report Series, No.894.
4. Groop L, Orho-Melander M. The dysmetabolic syndrome. J Intern Med 2001; 250:105-120. (Pubitemid 32868690)
5. Hanefeld M, Schaper F, Ceriello A. Geschichte und Definition(en) des metabolischen Syndroms. Internist 2007; 48:107-125.
6. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endo- criol Metab 2000; 10:327-332.
7. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89:2548-2556.
8. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ, Int J Obes Relat Metab Disord 1998; 22:1045-1058. (Pubitemid 28548534)
9. Fischer-Posovszky P, Wabitsch M. Entwicklung und Funktion des Fettgewebes. Monatsschr Kinderheilkd 2004; 152:834-842 (Pubitemid 39186696)
10. Trayhurn P. Adipocyte biology. Obes Rev 2007; 8 (Suppl.l): 41-44. (Pubitemid 46272580)
11. Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 2003; 46:1594-1603. (Pubitemid 38005321)
12. Pittas AG, Joseph NA, Greenberg AS. Adipocytokines and Insulin Resistance. J Clin Endocrinol Metab 2004; 89:447-452.
13. Ronti T, Lupattelli G, Monnarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol 2006; 64:355-365.
14. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001; 60:349-356.
15. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome 2005. www.idf.org
16. Wallace TM, Levy JC, Matthews DR. Use and Abuse of HOMA Modeling. Diabetes Care 2004; 27:1487-1495.
17. Anand SS, Yi Q, Gerstein H et al. Relationship of Metabolic Syndrome and Fibrinolytic Dysfunction to Cardiovascular Disease. Circulation 2003; 108:420-425. (Pubitemid 36935534)
18. Xydakis AM, Case CC, Jones PH et al. Adiponectin, Inflammation, and the Expression of the Metabolic Syndrome in Obese Individuals: The Impact of Rapid Weight Loss through Caloric Restriction. J Clin Endocrinol Metab 2004; 89:2697-2703.
19. You T, Ryan AS, Niclas B. The Metabolic Syndrome in Obese Postmenopausal Women: Relationship to Body Composition, Visceral Fat, and Inflammation. J Clin Endocrinol Metab 2004; 89:5517-5522. (Pubitemid 39518435)
20. Shaibi GQ, Cruz ML, Weigensberg MJ et al. Adiponectin Independently Predict Metabolic Syndrome in Overweight Latino Youth. J Clin Endocrinol Metab 2007; 92:1809-1813.
21. Matsushita K, Yatsuya H, Tamakoshi K et al. Comparison of Circulating Adiponectin and Proinflammatory Markers Regarding Their Association With Metabolic Syndrome in Japanese Men. Arterioscler Thromb Vase Biol 2006; 26:871-876. (Pubitemid 43732165)
22. Ryo M, Nakamura T, Kihara S et al. Adiponectin as a Biomarker of the Metabolic Syndrome. Cire J 2004; 68:975-981. (Pubitemid 39540124)
23. Bahia L, Aguiar LG, Villela N et al. Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome. Clinics 2006; 61:433-440. (Pubitemid 44639403)
24. Komatsu M, Ohfusa H, Aizawa T et al. Adiponectin Inversely Correlates with High Sensitive C-reactive Protein and Triglycerides, but not with Insulin Sensitivity, in Apparently Healthy Japanese Men. Endocr J 2007; 54:553-558. (Pubitemid 47414602)
25. Sharma AM, Tarnopolsky MA. Regulating adiponectin: of flax and flux. Diabetologia 2005; 48:1035-1037.
26. Trujillo ME, Scherer PE. Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Int Med 2005; 257:167-175.
27. Rogulski L, Lisikiewicz B, Nowak R. Stȩzenie TNF-α w osoczu otyłych pacjentów z zespołem metabolicznym. Diabetologia Doświadczalna i Kliniczna 2005; 5:381-385.
28. Ridker PM, Buring JE, Cook NR et al. C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events. Circulation 2003; 107:391-397.
29. Festa A, D'Agostino R, Howard G et al. Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome. Circulation 2000; 102: 42-47.
30. Frölich M, Imhof A, Berg G. Association Between C-Reactive Protein and Features of the Metabolic Syndrome. Diabetes Care 2000; 23:1835-1839.
31. Ford ES, Ajani UA, Mokdad AH. The Metabolic Syndrome and Concentrations of C-Reactive Protein Among U.S. Youth. Diabetes Care 2005; 28: 878-881. (Pubitemid 40434489)
32. Shand BI, Scott RS, Elder PA et al. Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistnee. Diabetes Obes Metab 2003; 5:349-353.
33. Baratta R, Amato S, Degano C et al. Adiponectin Relationship with Lipid Metabolism is Independent of Body Fat Mass: Evidence from Both Cross-Sectional and Interventional Studies. J Clin Endocrinol Metab 2004; 89: 2665-2671. (Pubitemid 38766347)
34. Bruun JM, Lihn AS, Verdich C et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003; 285: E527-E533. (Pubitemid 37010830)
35. Cnop M, Havel PJ, Utzschneider KM et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteines: evidence for independent roles of age and sex. Diabetologia 2003; 46:459-469. (Pubitemid 36577787)
36. Altinova At, Toruner F, Bukan N et al. Decreased Plasma Adiponectin is Associated with Insulin Resistance and HDL Cholesterol in Overweight Subjects. Endocr J 2007; 54:221-226. (Pubitemid 46798643)
37. Shaibi GQ, Cruz ML, Weigensberg MJ et al. Adiponectin Independently Predict Metabolic Syndrome in Overweight Latino Youth. J Clin Endocrinol Metab 2007; 92:1809-1813.
38. Ryo M, Nakamura T, Kihara S et al. Adiponectin as a Biomarker of the Metabolic Syndrome. Cire J 2004; 68:975-981. (Pubitemid 39540124)